Nur Syazana Aziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nur Syazana Aziz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Swee-Seong Tang
Division of Microbiology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
3 shared publications - Anisah Azhar
Institute for Advanced Studies (IAS), Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication - Muhamad Nizar Amir
Universiti Malaya
1 shared publication - Norhafiza Mohd Arshad
Centre for Research in Biotechnology for Agriculture (CEBAR), Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication - Norhidayah Mohd Taufek
Aqua Nutri Biotechnology Laboratory, Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication - Subha Bhassu
Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, 50603, Malaysia
1 shared publication
Latest Publications
- Open Access
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Alginate-Chitosan Oligosaccharide Microencapsulation of a Lytic Bacteriophages Targeting Multidrug-Resistant Klebsiella pneumoniae from Malaysian Aquaculture
Intensive Oreochromis spp. (tilapia) aquaculture faces increasing threats from bacterial infections and antimicrobial resistance (AMR). This study investigated disease outbreaks in floating cages along the Sungai Temerloh River, Malaysia, where tilapia and patin were co-cultured. Diseased patin exhibited yellowish body discoloration, skin lesions, cloudy eyes, S-shaped spinal curvature, and tail rot, while tilapia showed scoliosis, pale yellow skin, ascites, and exophthalmia; no parasitic infestations were detected. Ten bacterial isolates were recovered from internal organs, comprising Aeromonas, Klebsiella, Plesiomonas, and Edwardsiella spp. Klebsiella pneumoniae (KP001), isolated from patin eyes, was prioritized due to confirmed pathogenicity in red hybrid tilapia (LD50 = 4.6 × 106 CFU/fish) and multidrug-resistant profile (MAR index = 0.4), exhibiting resistance to ampicillin, amoxicillin, ceftriaxone, and cefepime. A lytic bacteriophage, KPP5, targeting KP001, was isolated from the same environment and encapsulated within alginate–chitosan oligosaccharide (COS) microcapsules to improve phage stability and facilitate future oral delivery. Transmission Electron Microscopy confirmed intact phage particles within the capsules (capsid: 93.1 ± 3.2 nm; tail: 140.1 nm), while Scanning Electron Microscopy revealed spherical microcapsules with reduced mean diameters after phage loading (SEM: 0.403 → 0.173 µm; DLS: 3.207 → 2.095 µm). Fourier Transform Infrared spectroscopy indicated Ca2+-mediated crosslinking, COS–alginate interactions, and phage incorporation. Encapsulation efficiency was high (87.8 ± 3.3%), preserving phage viability (~107–108 PFU/mL). These findings demonstrate the emergence of multidrug-resistant K. pneumoniae in co-cultured aquaculture systems and highlight alginate–COS microencapsulation as an effective approach to preserve phage integrity and lytic activity for sustainable bacterial disease management.
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAlginate-Chitosan Oligosaccharide Microencapsulation of a Lytic Bacteriophages Targeting Multidrug-Resistant Klebsiella pneumoniae from Malaysian Aquaculture
Intensive Oreochromis spp. (tilapia) aquaculture faces increasing threats from bacterial infections and antimicrobial resistance (AMR). This study investigated disease outbreaks in floating cages along the Sungai Temerloh River, Malaysia, where tilapia and patin were co-cultured. Diseased patin exhibited yellowish body discoloration, skin lesions, cloudy eyes, S-shaped spinal curvature, and tail rot, while tilapia showed scoliosis, pale yellow skin, ascites, and exophthalmia; no parasitic infestations were detected. Ten bacterial isolates were recovered from internal organs, comprising Aeromonas, Klebsiella, Plesiomonas, and Edwardsiella spp. Klebsiella pneumoniae (KP001), isolated from patin eyes, was prioritized due to confirmed pathogenicity in red hybrid tilapia (LD50 = 4.6 × 106 CFU/fish) and multidrug-resistant profile (MAR index = 0.4), exhibiting resistance to ampicillin, amoxicillin, ceftriaxone, and cefepime. A lytic bacteriophage, KPP5, targeting KP001, was isolated from the same environment and encapsulated within alginate–chitosan oligosaccharide (COS) microcapsules to improve phage stability and facilitate future oral delivery. Transmission Electron Microscopy confirmed intact phage particles within the capsules (capsid: 93.1 ± 3.2 nm; tail: 140.1 nm), while Scanning Electron Microscopy revealed spherical microcapsules with reduced mean diameters after phage loading (SEM: 0.403 → 0.173 µm; DLS: 3.207 → 2.095 µm). Fourier Transform Infrared spectroscopy indicated Ca2+-mediated crosslinking, COS–alginate interactions, and phage incorporation. Encapsulation efficiency was high (87.8 ± 3.3%), preserving phage viability (~107–108 PFU/mL). These findings demonstrate the emergence of multidrug-resistant K. pneumoniae in co-cultured aquaculture systems and highlight alginate–COS microencapsulation as an effective approach to preserve phage integrity and lytic activity for sustainable bacterial disease management.
- 20 April 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (7) , 345
Therapeutic and immunomodulatory effects of phage therapy in red hybrid tilapia challenged with Klebsiella pneumoniae
The increasing prevalence of antibiotic-resistant Klebsiella pneumoniae poses a serious threat to aquaculture sustainability and fish health. This study evaluated the therapeutic efficacy and immunomodulatory effects of Klebsiella pneumoniae Phage 5 (KPP5) in red hybrid tilapia experimentally challenged with K. pneumoniae strain 001 (KP001). In vitro characterisation demonstrated that the phage exhibited strong lytic activity, rapid replication, and a high burst size against the target bacterium. An in vivo challenge model was established to assess disease progression, survival, bacterial clearance, phage persistence, and host immune responses following intraperitoneal administration. Phage-treated fish exhibited a 41.67% relative survival, a complete hepatic bacterial clearance, and a sustained phage persistence. Phage titres persisted longer in infected fish, indicating active replication in the presence of the bacterial host. Immunological analyses revealed that phage therapy moderated excessive inflammatory responses while enhancing protective immunity, as evidenced by stabilised protein levels, regulated complement activity, partial restoration of lysozyme activity, and significantly elevated immunoglobulin M (IgM) concentrations in both serum and mucus. These findings demonstrate that KPP5 provides dual benefits through effective bacterial control and modulation of innate and adaptive immune responses. Overall, this study supports the potential of bacteriophage therapy as a safe and promising alternative strategy for managing antibiotic-resistant bacterial infections in aquaculture. This study was registered with the Institutional Animal Care and Use Committee (IACUC) of Universiti Malaya (Ref: G8/10032025/07012025-02/R).
- 20 April 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (7) , 345
Therapeutic and immunomodulatory effects of phage therapy in red hybrid tilapia challenged with Klebsiella pneumoniae
The increasing prevalence of antibiotic-resistant Klebsiella pneumoniae poses a serious threat to aquaculture sustainability and fish health. This study evaluated the therapeutic efficacy and immunomodulatory effects of Klebsiella pneumoniae Phage 5 (KPP5) in red hybrid tilapia experimentally challenged with K. pneumoniae strain 001 (KP001). In vitro characterisation demonstrated that the phage exhibited strong lytic activity, rapid replication, and a high burst size against the target bacterium. An in vivo challenge model was established to assess disease progression, survival, bacterial clearance, phage persistence, and host immune responses following intraperitoneal administration. Phage-treated fish exhibited a 41.67% relative survival, a complete hepatic bacterial clearance, and a sustained phage persistence. Phage titres persisted longer in infected fish, indicating active replication in the presence of the bacterial host. Immunological analyses revealed that phage therapy moderated excessive inflammatory responses while enhancing protective immunity, as evidenced by stabilised protein levels, regulated complement activity, partial restoration of lysozyme activity, and significantly elevated immunoglobulin M (IgM) concentrations in both serum and mucus. These findings demonstrate that KPP5 provides dual benefits through effective bacterial control and modulation of innate and adaptive immune responses. Overall, this study supports the potential of bacteriophage therapy as a safe and promising alternative strategy for managing antibiotic-resistant bacterial infections in aquaculture. This study was registered with the Institutional Animal Care and Use Committee (IACUC) of Universiti Malaya (Ref: G8/10032025/07012025-02/R).
- 19 October 2025
- Published by Springer Nature
- p. 67-79
Effects of Various Environmental Conditions on the Stability of Single-Layer Alginate Microcapsules
- 19 October 2025
- Published by Springer Nature
- p. 67-79
Effects of Various Environmental Conditions on the Stability of Single-Layer Alginate Microcapsules